טוען...
Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial
AIMS : To compare the safety and efficacy of edoxaban combined with P2Y(12) inhibition following percutaneous coronary intervention (PCI) in patients with atrial fibrillation (AF) presenting with an acute coronary syndrome (ACS) or chronic coronary syndrome (CCS). METHODS AND RESULTS : In this pre-s...
שמור ב:
| הוצא לאור ב: | Eur Heart J |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7767635/ https://ncbi.nlm.nih.gov/pubmed/32860041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehaa617 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|